Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) is now available.
Imricor Medical Systems, Inc. announced a change in the director’s interest, specifically for Mr. Peter McGregor, who acquired additional CHESS Depositary Interests (CDIs) under the company’s Equity Incentive Plan (EIP). This acquisition, approved at the recent AGM, reflects the company’s ongoing commitment to aligning director interests with shareholder value, potentially impacting its governance and stakeholder confidence positively.
The most recent analyst rating on (AU:IMR) stock is a Buy with a A$2.28 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.
More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc. operates in the medical technology industry, focusing on the development and commercialization of MRI-compatible products. The company is known for its innovative solutions that enhance MRI-guided procedures, particularly in the field of cardiac electrophysiology.
Average Trading Volume: 417,906
For a thorough assessment of IMR stock, go to TipRanks’ Stock Analysis page.